Leading Personalized Patient Health Network PatientsLikeMe Raises $26 Million to Support Next Phase of Growth
Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore,
Medical device manufacturer New Horizon Health has pulled in early demand to cover its Hong Kong IPO multiple times over, according to a source familiar with the matter.
Charlesbank Capital Partners has held a final closing of its newest flagship fund, Charlesbank Equity Fund X LP, at its hard cap with $3.75 billion of capital. Fundraising for the new fund was launch just
Soleus Capital has led a $35m series-C funding round extension in cancer genomics company Inivata.
New Horizon Health hit the equities market on Thursday, aiming to raise up to HK$2.04bn ($263.1m) from its IPO, according to a source familiar with the matter.
BGF has sold dialysis services provider Renal Services to healthcare group DaVita UK.
Global Healthcare Opportunities (GHO) has appointed David W Miller and Geoffrey Hamilton-Fairley as operating partners.
Mertz Taggart reaches a new milestone of over 100 successfully completed transactions.(PRWeb February 04, 2021)Read the full story at https://www.prweb.com/releases/healthcare_m_a_transaction_recap_for_the_year_2020/prweb17706450.htm
Chinese biopharmaceutical duo WuXi Biologics (Cayman) and InnoCare Pharma raised a combined HK$16.2bn ($2.1bn) on Tuesday from selling new stock.
Private equity giant Carlyle has teamed with with Brighton Park Capital to invest in Bangalore-headquartered enterprise healthtech solutions provider Indegene.
The operations divested from the Japanese business include Shiseido’s well-known drugstore brands, such as Tsubaki hair care products and Senka face wash
Moonpig, the online greetings card company, was trading over 20% above its IPO price on Tuesday, netting a healthy profit for investors and showing another example of IPO resilience amidst recent equity market volatility.